BillionToOne Inc (BLLN)

• Market cap: $4.11B
• 1 day: 4.61%
• 5 days: 4.9%
• 1 month: -9.54%
• 3 months: -11.9%
• 6 months: -17.67%
• Year to date: 0.45%
• 1 year: -17.67%
• 5 years: -17.67%
• 10 years: -17.67%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.